Davis Polk advised the joint-bookrunning managers and representatives of the several underwriters in the offering. Five Prime Therapeutics, Inc. executed an approximately $173.8 million public offering…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now